Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    David Moore

    TitleAssociate Professor In Residence
    SchoolUniversity of California, San Diego
    DepartmentPsychiatry
    Address200 W. Arbor Drive #8231
    CA San Diego 92103
    Phone619-543-5093
    vCardDownload vCard

      Collapse Overview 
      Collapse Overview

      Biography

      Dr. Moore received his doctorate from the SDSU/UCSD Joint Doctoral Program in Clinical Psychology with a specialization in neuropsychology. After completing his clinical internship at the West Los Angeles VA, he returned to UCSD for a post-doctoral fellowship focusing on individuals with serious mental illness. Currently, he is a licensed clinical psychologist and an Associate Professor conducting research at the HIV Neurobehavioral Research Program (HNRP). He focuses on neurocognitive impairment and daily functioning difficulty among persons with co-occurring HIV infection, serious mental illness, and substance use disorders. He has a particularly interest in technological interventions to improve medication adherence. Dr. Moore is also a faculty member of the SDSU/UCSD Joint Doctoral Program in Clinical Psychology.

      Research Interests

      Dr. Moore’s research focuses on the neuropsychological and everyday functioning difficulties of individuals with HIV infection He is a Principal Investigator on several ongoing HIV-related research studies that are supported by NIMH, NIDA, and the California HIV/AIDS Research Program (CHRP). One of his primary research foci is examining the neurocognitive complications associated with HIV infection and other comorbid disorders (e.g., psychiatric and substance use disorders) and how neurocognitive difficulties relate to everyday functioning. In addition, Dr. Moore has a keen interest in the intersection of HIV and aging, and in identifying factors associated with successfully aging with HIV infection. Much of his recent work has focused on developing innovative, personalized, scalable text messaging interventions to improve antiretroviral medication adherence.


      Collapse Research 
      Collapse Research Activities and Funding
      California NeuroAIDS Tissue Network
      NIH/NIMH U24MH100928May 1, 2013 - Apr 30, 2018
      Role: Principal Investigator
      Multi-Dimensional Successful Aging Among HIV-Infected Adults
      NIH/NIMH R01MH099987Jan 1, 2013 - Dec 31, 2017
      Role: Principal Investigator
      A multi-systems study of HIV neuropathogenesis: genetics-neuropathology-behavior
      NIH/NIMH R01MH096648Sep 6, 2012 - Jun 30, 2017
      Role: Principal Investigator
      Personalized Text Messages to Improve ART Adherence in HIV+ Methamphetamine Users
      NIH/NIDA R34DA031058Apr 15, 2011 - Mar 31, 2014
      Role: Principal Investigator
      Medication Adherence Among Bipolar Patients with Comorbid HIV Infection
      NIH/NIMH R03MH078785Dec 6, 2006 - Nov 30, 2008
      Role: Principal Investigator

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Marquine MJ, Heaton A, Johnson N, Rivera-Mindt M, Cherner M, Bloss C, Hulgan T, Umlauf A, Moore D, Fazeli P, Morgello S, Franklin D, Letendre S, Ellis R, Collier AC, Marra CM, Clifford DB, Gelman BB, Sacktor N, Simpson D, McCutchan JA, Grant I, Heaton RK. Differences in Neurocognitive Impairment Among HIV-Infected Latinos in the United States. J Int Neuropsychol Soc. 2017 Sep 06; 1-13. PMID: 28874213.
        View in: PubMed
      2. Moore RC, Paolillo EW, Heaton A, Fazeli PL, Jeste DV, Moore D. Clinical utility of the UCSD Performance-Based Skills Assessment-Brief (UPSA-B) in adults living with HIV: Associations with neuropsychological impairment and patient-reported everyday functioning difficulties. PLoS One. 2017; 12(8):e0183614. PMID: 28837678.
        View in: PubMed
      3. Paolillo EW, Gongvatana A, Umlauf A, Letendre SL, Moore D. At-Risk Alcohol Use is Associated with Antiretroviral Treatment Nonadherence Among Adults Living with HIV/AIDS. Alcohol Clin Exp Res. 2017 Aug; 41(8):1518-1525. PMID: 28679147.
        View in: PubMed
      4. Christensen B, Qin Z, Byrd DA, Yu F, Morgello S, Gelman BB, Moore D, Grant I, Singer EJ, Fox HS, Baccaglini L. Measures of Physical and Mental Independence Among HIV-Positive Individuals: Impact of Substance Use Disorder. AIDS Res Hum Retroviruses. 2017 Apr 10. PMID: 28288515.
        View in: PubMed
      5. Montoya JL, Iudicello J, Oppenheim HA, Fazeli PL, Potter M, Ma Q, Mills PJ, Ellis RJ, Grant I, Letendre SL, Moore D. Coagulation imbalance and neurocognitive functioning in older HIV-positive adults on suppressive antiretroviral therapy. AIDS. 2017 Mar 27; 31(6):787-795. PMID: 28099190.
        View in: PubMed
      6. Sakoda ME, Fazeli PL, Ellis RJ, Jeste DV, Grant I, Letendre SL, Moore D. Higher Cystatin C Levels Are Associated With Neurocognitive Impairment in Older HIV+ Adults. J Acquir Immune Defic Syndr. 2017 Mar 01; 74(3):243-249. PMID: 27861242.
        View in: PubMed
      7. Eyawo O, Franco-Villalobos C, Hull MW, Nohpal A, Samji H, Sereda P, Lima VD, Shoveller J, Moore D, Montaner JS, Hogg RS. Changes in mortality rates and causes of death in a population-based cohort of persons living with and without HIV from 1996 to 2012. BMC Infect Dis. 2017 Feb 27; 17(1):174. PMID: 28241797.
        View in: PubMed
      8. Moore RC, Marquine MJ, Straus E, Depp CA, Moore D, Schiehser DM, Richtand NM, Jeste DV, Eyler LT. Predictors and Barriers to Mental Health Treatment Utilization Among Older Veterans Living With HIV. Prim Care Companion CNS Disord. 2017 Feb 02; 19(1). PMID: 28157277.
        View in: PubMed
      9. Montoya JL, Iudicello J, Fazeli PL, Hong S, Potter M, Ellis RJ, Grant I, Letendre SL, Moore D. Elevated Markers of Vascular Remodeling and Arterial Stiffness Are Associated With Neurocognitive Function in Older HIV+ Adults on Suppressive Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2017 Feb 01; 74(2):134-141. PMID: 27828873.
        View in: PubMed
      10. Fazeli PL, Casaletto KB, Paolillo E, Moore RC, Moore D. Screening for neurocognitive impairment in HIV-positive adults aged 50 years and older: Montreal Cognitive Assessment relates to self-reported and clinician-rated everyday functioning. J Clin Exp Neuropsychol. 2017 Nov; 39(9):842-853. PMID: 28122474.
        View in: PubMed
      11. Flores I, Casaletto KB, Marquine MJ, Umlauf A, Moore D, Mungas D, Gershon RC, Beaumont JL, Heaton RK. Performance of Hispanics and Non-Hispanic Whites on the NIH Toolbox Cognition Battery: the roles of ethnicity and language backgrounds. Clin Neuropsychol. 2017 May; 31(4):783-797. PMID: 28080261.
        View in: PubMed
      12. Wallace LM, Ferrara M, Brothers TD, Garlassi S, Kirkland SA, Theou O, Zona S, Mussini C, Moore D, Rockwood K, Guaraldi G. Lower Frailty Is Associated with Successful Cognitive Aging Among Older Adults with HIV. AIDS Res Hum Retroviruses. 2017 Feb; 33(2):157-163. PMID: 27869500.
        View in: PubMed
      13. Gianella S, Taylor J, Brown TR, Kaytes A, Achim CL, Moore D, Little SJ, Ellis RJ, Smith DM. Can research at the end of life be a useful tool to advance HIV cure? AIDS. 2017 Jan 02; 31(1):1-4. PMID: 27755112.
        View in: PubMed
      14. Dufour CA, Marquine MJ, Fazeli PL, Umlauf A, Henry BL, Zlatar Z, Montoya JL, Ellis RJ, Grant I, Moore D. A Longitudinal Analysis of the Impact of Physical Activity on Neurocognitive Functioning Among HIV-Infected Adults. AIDS Behav. 2016 Dec 19. PMID: 27990580.
        View in: PubMed
      15. Moore RC, Kaufmann CN, Rooney AS, Moore D, Eyler LT, Granholm E, Woods SP, Swendsen J, Heaton RK, Scott JC, Depp CA. Feasibility and Acceptability of Ecological Momentary Assessment of Daily Functioning Among Older Adults with HIV. Am J Geriatr Psychiatry. 2017 Aug; 25(8):829-840. PMID: 28065496.
        View in: PubMed
      16. Kim J, Nanfuka M, Moore D, Shafic M, Nyonyitono M, Birungi J, Galenda F, King R. 'People say that we are already dead much as we can still walk': a qualitative investigation of community and couples' understanding of HIV serodiscordance in rural Uganda. BMC Infect Dis. 2016 Nov 10; 16(1):665. PMID: 27832759.
        View in: PubMed
      17. Hoenigl M, Chaillon A, Moore D, Morris SR, Mehta SR, Gianella S, Amico KR, Little SJ. Rapid HIV Viral Load Suppression in those Initiating Antiretroviral Therapy at First Visit after HIV Diagnosis. Sci Rep. 2016 Sep 06; 6:32947. PMID: 27597312; PMCID: PMC5011704.
      18. Marquine MJ, Montoya JL, Umlauf A, Fazeli PL, Gouaux B, Heaton RK, Ellis RJ, Letendre SL, Grant I, Moore D. The Veterans Aging Cohort Study (VACS) Index and Neurocognitive Change: A Longitudinal Study. Clin Infect Dis. 2016 Sep 01; 63(5):694-702. PMID: 27199461; PMCID: PMC4981756 [Available on 09/01/17].
      19. Soontornniyomkij V, Umlauf A, Soontornniyomkij B, Batki IB, Moore D, Masliah E, Achim CL. Lifetime methamphetamine dependence is associated with cerebral microgliosis in HIV-1-infected adults. J Neurovirol. 2016 Oct; 22(5):650-660. PMID: 27098516.
        View in: PubMed
      20. Hoenigl M, Chaillon A, Moore D, Morris SR, Smith DM, Little SJ. Clear Links Between Starting Methamphetamine and Increasing Sexual Risk Behavior: A Cohort Study Among Men Who Have Sex With Men. J Acquir Immune Defic Syndr. 2016 Apr 15; 71(5):551-7. PMID: 26536321; PMCID: PMC4788567 [Available on 04/15/17].
      21. Montoya JL, Cattie J, Morgan E, Woods SP, Cherner M, Moore D, Atkinson JH, Grant I. The impact of age, HIV serostatus and seroconversion on methamphetamine use. Am J Drug Alcohol Abuse. 2016 Mar; 42(2):168-77. PMID: 26837461; PMCID: PMC4842208 [Available on 03/01/17].
      22. Casaletto KB, Moore D, Woods SP, Umlauf A, Scott JC, Heaton RK. Abbreviated Goal Management Training Shows Preliminary Evidence as a Neurorehabilitation Tool for HIV-associated Neurocognitive Disorders among Substance Users. Clin Neuropsychol. 2016; 30(1):107-30. PMID: 26753986; PMCID: PMC4801659.
      23. Henry BL, Moore D. Preliminary Findings Describing Participant Experience With iSTEP, an mHealth Intervention to Increase Physical Activity and Improve Neurocognitive Function in People Living With HIV. J Assoc Nurses AIDS Care. 2016 Jul-Aug; 27(4):495-511. PMID: 26847379; PMCID: PMC4903897 [Available on 07/01/17].
      24. Fazeli PL, Moore D, Franklin DR, Umlauf A, Heaton RK, Collier AC, Marra CM, Clifford DB, Gelman BB, Sacktor NC, Morgello S, Simpson DM, McCutchan JA, Grant I, Letendre SL. Lower CSF Aß is Associated with HAND in HIV-Infected Adults with a Family History of Dementia. Curr HIV Res. 2016; 14(4):324-30. PMID: 26673902; PMCID: PMC4916008 [Available on 01/01/17].
      25. Casaletto KB, Kwan S, Montoya JL, Obermeit LC, Gouaux B, Poquette A, Heaton RK, Atkinson JH, Moore D. Predictors of psychotropic medication adherence among HIV+ individuals living with bipolar disorder. Int J Psychiatry Med. 2016; 51(1):69-83. PMID: 26681237.
        View in: PubMed
      26. Marquine MJ, Sakamoto M, Dufour C, Rooney A, Fazeli P, Umlauf A, Gouaux B, Franklin D, Ellis R, Letendre S, Cherner M, Heaton RK, Grant I, Moore D. The impact of ethnicity/race on the association between the Veterans Aging Cohort Study (VACS) Index and neurocognitive function among HIV-infected persons. J Neurovirol. 2016 Aug; 22(4):442-54. PMID: 26679535; PMCID: PMC4912471 [Available on 08/01/17].
      27. Bryant AK, Fazeli PL, Letendre SL, Ellis RJ, Potter M, Burdo TH, Singh KK, Jeste DV, Grant I, Moore D. Complement Component 3 Is Associated with Metabolic Comorbidities in Older HIV-Positive Adults. AIDS Res Hum Retroviruses. 2016 Mar; 32(3):271-8. PMID: 26499082; PMCID: PMC4779974 [Available on 03/01/17].
      28. Levine AJ, Soontornniyomkij V, Achim CL, Masliah E, Gelman BB, Sinsheimer JS, Singer EJ, Moore D. Multilevel analysis of neuropathogenesis of neurocognitive impairment in HIV. J Neurovirol. 2016 Aug; 22(4):431-41. PMID: 26637429; PMCID: PMC4893344 [Available on 08/01/17].
      29. Montoya JL, Wing D, Knight A, Moore D, Henry BL. Development of an mHealth Intervention (iSTEP) to Promote Physical Activity among People Living with HIV. J Int Assoc Provid AIDS Care. 2015 Nov-Dec; 14(6):471-5. PMID: 26307212; PMCID: PMC4654667.
      30. Thames AD, Briones MS, Magpantay LI, Martinez-Maza O, Singer EJ, Hinkin CH, Morgello S, Gelman BB, Moore D, Heizerling K, Levine AJ. The role of chemokine C-C motif ligand 2 genotype and cerebrospinal fluid chemokine C-C motif ligand 2 in neurocognition among HIV-infected patients. AIDS. 2015 Jul 31; 29(12):1483-91. PMID: 26244388; PMCID: PMC4573552.
      31. Moore RC, Fazeli PL, Patterson TL, Depp CA, Moore D, Granholm E, Jeste DV, Mausbach BT. UPSA-M: Feasibility and initial validity of a mobile application of the UCSD Performance-Based Skills Assessment. Schizophr Res. 2015 May; 164(1-3):187-92. PMID: 25790903; PMCID: PMC4409538.
      32. Moore D, Poquette A, Casaletto KB, Gouaux B, Montoya JL, Posada C, Rooney AS, Badiee J, Deutsch R, Letendre SL, Depp CA, Grant I, Atkinson JH. Individualized texting for adherence building (iTAB): improving antiretroviral dose timing among HIV-infected persons with co-occurring bipolar disorder. AIDS Behav. 2015 Mar; 19(3):459-71. PMID: 25504449; PMCID: PMC4359057.
      33. Casaletto KB, Cattie J, Franklin DR, Moore D, Woods SP, Grant I, Heaton RK. The Wide Range Achievement Test-4 Reading subtest "holds" in HIV-infected individuals. J Clin Exp Neuropsychol. 2014; 36(9):992-1001. PMID: 25283135; PMCID: PMC4241141.
      34. Montoya JL, Georges S, Poquette A, Depp CA, Atkinson JH, Moore D. Refining a personalized mHealth intervention to promote medication adherence among HIV+ methamphetamine users. AIDS Care. 2014; 26(12):1477-81. PMID: 24911433; PMCID: PMC4188758.
      35. Moore RC, Fazeli PL, Jeste DV, Moore D, Grant I, Woods SP. Successful cognitive aging and health-related quality of life in younger and older adults infected with HIV. AIDS Behav. 2014 Jun; 18(6):1186-97. PMID: 24633788; PMCID: PMC4020963.
      36. Fazeli PL, Doyle KL, Scott JC, Iudicello JE, Casaletto KB, Weber E, Moore D, Morgan EE, Grant I, Woods SP. Shallow encoding and forgetting are associated with dependence in instrumental activities of daily living among older adults living with HIV infection. Arch Clin Neuropsychol. 2014 May; 29(3):278-88. PMID: 24695591; PMCID: PMC4000232.
      37. Fazeli PL, Woods SP, Heaton RK, Umlauf A, Gouaux B, Rosario D, Moore RC, Grant I, Moore D. An active lifestyle is associated with better neurocognitive functioning in adults living with HIV infection. J Neurovirol. 2014 Jun; 20(3):233-42. PMID: 24554483; PMCID: PMC4040153.
      38. Montaner JS, Lima VD, Harrigan PR, Lourenço L, Yip B, Nosyk B, Wood E, Kerr T, Shannon K, Moore D, Hogg RS, Barrios R, Gilbert M, Krajden M, Gustafson R, Daly P, Kendall P. Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the "HIV Treatment as Prevention" experience in a Canadian setting. PLoS One. 2014; 9(2):e87872. PMID: 24533061; PMCID: PMC3922718.
      39. Doyle KL, Morgan EE, Morris S, Smith DM, Little S, Iudicello JE, Blackstone K, Moore D, Grant I, Letendre SL, Woods SP. Real-world impact of neurocognitive deficits in acute and early HIV infection. J Neurovirol. 2013 Dec; 19(6):565-73. PMID: 24277439; PMCID: PMC3865175.
      40. Moore D, Montoya JL, Blackstone K, Rooney A, Gouaux B, Georges S, Depp CA, Atkinson JH, Tmarc Group T. Preliminary Evidence for Feasibility, Use, and Acceptability of Individualized Texting for Adherence Building for Antiretroviral Adherence and Substance Use Assessment among HIV-Infected Methamphetamine Users. AIDS Res Treat. 2013; 2013:585143. PMID: 24078868; PMCID: PMC3776360.
      41. Montoya JL, Umlauf A, Abramson I, Badiee J, Woods SP, Atkinson JH, Grant I, Moore D. Dynamic indices of methamphetamine dependence and HIV infection predict fluctuations in affective distress: a five-year longitudinal analysis. J Affect Disord. 2013 Nov; 151(2):728-37. PMID: 24012068; PMCID: PMC3845675.
      42. Dufour CA, Marquine MJ, Fazeli PL, Henry BL, Ellis RJ, Grant I, Moore D. Physical exercise is associated with less neurocognitive impairment among HIV-infected adults. J Neurovirol. 2013 Oct; 19(5):410-7. PMID: 23934585; PMCID: PMC3795938.
      43. Blackstone K, Iudicello JE, Morgan EE, Weber E, Moore D, Franklin DR, Ellis RJ, Grant I, Woods SP. Human immunodeficiency virus infection heightens concurrent risk of functional dependence in persons with long-term methamphetamine use. J Addict Med. 2013 Jul-Aug; 7(4):255-63. PMID: 23648641; PMCID: PMC3737384.
      44. Moore RC, Moore D, Thompson WK, Vahia IV, Grant I, Jeste DV. A case-controlled study of successful aging in older HIV-infected adults. J Clin Psychiatry. 2013 May; 74(5):e417-23. PMID: 23759460; PMCID: PMC3683870.
      45. Gelman BB, Lisinicchia JG, Morgello S, Masliah E, Commins D, Achim CL, Fox HS, Kolson DL, Grant I, Singer E, Yiannoutsos CT, Sherman S, Gensler G, Moore D, Chen T, Soukup VM. Neurovirological correlation with HIV-associated neurocognitive disorders and encephalitis in a HAART-era cohort. J Acquir Immune Defic Syndr. 2013 Apr 15; 62(5):487-95. PMID: 23242157; PMCID: PMC3664102.
      46. Crum-Cianflone NF, Moore D, Letendre S, Poehlman Roediger M, Eberly L, Weintrob A, Ganesan A, Johnson E, Del Rosario R, Agan BK, Hale BR. Low prevalence of neurocognitive impairment in early diagnosed and managed HIV-infected persons. Neurology. 2013 Jan 22; 80(4):371-9. PMID: 23303852; PMCID: PMC3589242.
      47. Weber E, Morgan EE, Iudicello JE, Blackstone K, Grant I, Ellis RJ, Letendre SL, Little S, Morris S, Smith DM, Moore D, Woods SP. Substance use is a risk factor for neurocognitive deficits and neuropsychiatric distress in acute and early HIV infection. J Neurovirol. 2013 Feb; 19(1):65-74. PMID: 23250704; PMCID: PMC3568179.
      48. Soontornniyomkij V, Moore D, Gouaux B, Soontornniyomkij B, Tatro ET, Umlauf A, Masliah E, Levine AJ, Singer EJ, Vinters HV, Gelman BB, Morgello S, Cherner M, Grant I, Achim CL. Cerebral ß-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE e4 carriers. AIDS. 2012 Nov 28; 26(18):2327-35. PMID: 23018443; PMCID: PMC3576852.
      49. Moore D, Roediger MJ, Eberly LE, Blackstone K, Hale B, Weintrob A, Ganesan A, Agan BK, Letendre SL, Crum-Cianflone NF. Identification of an abbreviated test battery for detection of HIV-associated neurocognitive impairment in an early-managed HIV-infected cohort. PLoS One. 2012; 7(11):e47310. PMID: 23144815; PMCID: PMC3493574.
      50. Moore D, Posada C, Parikh M, Arce M, Vaida F, Riggs PK, Gouaux B, Ellis RJ, Letendre SL, Grant I, Atkinson JH. HIV-infected individuals with co-occurring bipolar disorder evidence poor antiretroviral and psychiatric medication adherence. AIDS Behav. 2012 Nov; 16(8):2257-66. PMID: 22041931; PMCID: PMC3351543.
      51. Poquette AJ, Moore D, Gouaux B, Morgan EE, Grant I, Woods SP. Prospective memory and antiretroviral medication non-adherence in HIV: an analysis of ongoing task delay length using the memory for intentions screening test. J Int Neuropsychol Soc. 2013 Feb; 19(2):155-61. PMID: 23095304; PMCID: PMC3693472.
      52. Blackstone K, Moore D, Franklin DR, Clifford DB, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, Ellis RJ, Atkinson JH, Grant I, Heaton RK. Defining neurocognitive impairment in HIV: deficit scores versus clinical ratings. Clin Neuropsychol. 2012; 26(6):894-908. PMID: 22708483; PMCID: PMC3848322.
      53. Badiee J, Riggs PK, Rooney AS, Vaida F, Grant I, Atkinson JH, Moore D. Approaches to identifying appropriate medication adherence assessments for HIV infected individuals with comorbid bipolar disorder. AIDS Patient Care STDS. 2012 Jul; 26(7):388-94. PMID: 22686169; PMCID: PMC3961000.
      54. Blackstone K, Tobin A, Posada C, Gouaux B, Grant I, Moore D. HIV-infected persons with bipolar disorder are less aware of memory deficits than HIV-infected persons without bipolar disorder. J Clin Exp Neuropsychol. 2012; 34(7):773-81. PMID: 22571839; PMCID: PMC3718038.
      55. Weber E, Blackstone K, Iudicello JE, Morgan EE, Grant I, Moore D, Woods SP. Neurocognitive deficits are associated with unemployment in chronic methamphetamine users. Drug Alcohol Depend. 2012 Sep 01; 125(1-2):146-53. PMID: 22560676; PMCID: PMC3735422.
      56. Moore D, Blackstone K, Woods SP, Ellis RJ, Atkinson JH, Heaton RK, Grant I. Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence. AIDS Care. 2012; 24(12):1504-13. PMID: 22530794; PMCID: PMC3466384.
      57. Soontornniyomkij V, Soontornniyomkij B, Moore D, Gouaux B, Masliah E, Tung S, Vinters HV, Grant I, Achim CL. Antioxidant sestrin-2 redistribution to neuronal soma in human immunodeficiency virus-associated neurocognitive disorders. J Neuroimmune Pharmacol. 2012 Sep; 7(3):579-90. PMID: 22450766; PMCID: PMC3573843.
      58. Crum-Cianflone NF, Roediger MP, Moore D, Hale B, Weintrob A, Ganesan A, Eberly LE, Johnson E, Agan BK, Letendre S. Prevalence and factors associated with sleep disturbances among early-treated HIV-infected persons. Clin Infect Dis. 2012 May; 54(10):1485-94. PMID: 22431801; PMCID: PMC3334363.
      59. Soontornniyomkij V, Everall IP, Moore D, Gouaux B, Tatro ET, Gospodarev V, Masliah E, Yin NS, Vinters HV, Achim CL. Increased cortical expression of FK506 binding protein-51 in HIV-associated neurocognitive disorders. J Neurovirol. 2012 Aug; 18(4):313-22. PMID: 22234543; PMCID: PMC3374917.
      60. Posada C, Moore D, Deutsch R, Rooney A, Gouaux B, Letendre S, Grant I, Atkinson JH. Sustained attention deficits among HIV-positive individuals with comorbid bipolar disorder. J Neuropsychiatry Clin Neurosci. 2012; 24(1):61-70. PMID: 22450615; PMCID: PMC3575087.
      61. Moore D, Keogh E, Eccleston C. The interruptive effect of pain on attention. Q J Exp Psychol (Hove). 2012; 65(3):565-86. PMID: 22136653.
        View in: PubMed
      62. Blackstone K, Moore D, Heaton RK, Franklin DR, Woods SP, Clifford DB, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, Rivera-Mindt M, Deutsch R, Ellis RJ, Hampton Atkinson J, Grant I. Diagnosing symptomatic HIV-associated neurocognitive disorders: self-report versus performance-based assessment of everyday functioning. J Int Neuropsychol Soc. 2012 Jan; 18(1):79-88. PMID: 22114912; PMCID: PMC3882265.
      63. Lyons JL, Uno H, Ancuta P, Kamat A, Moore D, Singer EJ, Morgello S, Gabuzda D. Plasma sCD14 is a biomarker associated with impaired neurocognitive test performance in attention and learning domains in HIV infection. J Acquir Immune Defic Syndr. 2011 Aug 15; 57(5):371-9. PMID: 21646912; PMCID: PMC3159710.
      64. Badiee J, Moore D, Atkinson JH, Vaida F, Gerard M, Duarte NA, Franklin D, Gouaux B, McCutchan JA, Heaton RK, McArthur J, Morgello S, Simpson D, Collier A, Marra CM, Gelman B, Clifford D, Grant I. Lifetime suicidal ideation and attempt are common among HIV+ individuals. J Affect Disord. 2012 Feb; 136(3):993-9. PMID: 21784531; PMCID: PMC3222733.
      65. Norman MA, Moore D, Taylor M, Franklin D, Cysique L, Ake C, Lazarretto D, Vaida F, Heaton RK. Demographically corrected norms for African Americans and Caucasians on the Hopkins Verbal Learning Test-Revised, Brief Visuospatial Memory Test-Revised, Stroop Color and Word Test, and Wisconsin Card Sorting Test 64-Card Version. J Clin Exp Neuropsychol. 2011 Aug; 33(7):793-804. PMID: 21547817; PMCID: PMC3154384.
      66. Singh KK, Nathamu S, Adame A, Alire TU, Dumaop W, Gouaux B, Moore D, Masliah E. Expression of mannose binding lectin in HIV-1-infected brain: implications for HIV-related neuronal damage and neuroAIDS. Neurobehav HIV Med. 2011 May 01; 3:41-52. PMID: 21852898.
        View in: PubMed
      67. Moore D, Williams DR. Emotional distress about weight gain and attitude to goal achievement failure as predictors of self-regulatory efficacy: does ethnicity make a difference? J Health Psychol. 2011 Sep; 16(6):895-904. PMID: 21441361.
        View in: PubMed
      68. Hladik W, Olara D, Mermin J, Moore D, Were W, Alexander L, Downing R. Effect of CD4+ T cell count and antiretroviral treatment on two serological HIV incidence assays. AIDS Res Hum Retroviruses. 2012 Jan; 28(1):95-9. PMID: 21314476.
        View in: PubMed
      69. Moore D, Arce M, Moseley S, McCutchan JA, Marquie-Beck J, Franklin DR, Vaida F, Achim CL, McArthur J, Morgello S, Simpson DM, Gelman BB, Collier AC, Marra CM, Clifford DB, Heaton RK, Grant I. Family history of dementia predicts worse neuropsychological functioning among HIV-infected persons. J Neuropsychiatry Clin Neurosci. 2011; 23(3):316-23. PMID: 21948893; PMCID: PMC3279193.
      70. Moore D, Letendre SL, Morris S, Umlauf A, Deutsch R, Smith DM, Little S, Rooney A, Franklin DR, Gouaux B, Leblanc S, Rosario D, Fennema-Notestine C, Heaton RK, Ellis RJ, Atkinson JH, Grant I. Neurocognitive functioning in acute or early HIV infection. J Neurovirol. 2011 Feb; 17(1):50-7. PMID: 21165782; PMCID: PMC3032208.
      71. Malaspina L, Woods SP, Moore D, Depp C, Letendre SL, Jeste D, Grant I. Successful cognitive aging in persons living with HIV infection. J Neurovirol. 2011 Feb; 17(1):110-9. PMID: 21165783; PMCID: PMC3032198.
      72. Posada C, Moore D, Woods SP, Vigil O, Ake C, Perry W, Hassanein TI, Letendre SL, Grant I. Implications of hepatitis C virus infection for behavioral symptoms and activities of daily living. J Clin Exp Neuropsychol. 2010 Jul; 32(6):637-44. PMID: 20603743; PMCID: PMC2898888.
      73. Tatro ET, Scott ER, Nguyen TB, Salaria S, Banerjee S, Moore D, Masliah E, Achim CL, Everall IP. Evidence for Alteration of Gene Regulatory Networks through MicroRNAs of the HIV-infected brain: novel analysis of retrospective cases. PLoS One. 2010 Apr 26; 5(4):e10337. PMID: 20436668; PMCID: PMC2859933.
      74. Moore D, Dray A, Green R, Hudson SL, Jenkinson R, Siokou C, Perez P, Bammer G, Maher L, Dietze P. Extending drug ethno-epidemiology using agent-based modelling. Addiction. 2009 Dec; 104(12):1991-7. PMID: 19804460.
        View in: PubMed
      75. Woods SP, Moore D, Weber E, Grant I. Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev. 2009 Jun; 19(2):152-68. PMID: 19462243; PMCID: PMC2690857.
      76. Khanlou N, Moore D, Chana G, Cherner M, Lazzaretto D, Dawes S, Grant I, Masliah E, Everall IP. Increased frequency of alpha-synuclein in the substantia nigra in human immunodeficiency virus infection. J Neurovirol. 2009 Apr; 15(2):131-8. PMID: 19115126; PMCID: PMC3979854.
      77. Moore D, Moseley S, Palmer BW. A guide for considering performance-based assessments when determining a patient's capacity for safe, independent living. Geriatrics. 2008 Sep 01; 63(9):16-20. PMID: 18763847.
        View in: PubMed
      78. Depp CA, Savla GN, Moore D, Palmer BW, Stricker JL, Lebowitz BD, Jeste DV. Short-term course of neuropsychological abilities in middle-aged and older adults with bipolar disorder. Bipolar Disord. 2008 Sep; 10(6):684-90. PMID: 18837862; PMCID: PMC2575128.
      79. Lamond AJ, Depp CA, Allison M, Langer R, Reichstadt J, Moore D, Golshan S, Ganiats TG, Jeste DV. Measurement and predictors of resilience among community-dwelling older women. J Psychiatr Res. 2008 Dec; 43(2):148-54. PMID: 18455190; PMCID: PMC2613196.
      80. Rosenberg D, Kerr J, Sallis JF, Patrick K, Moore D, King A. Feasibility and outcomes of a multilevel place-based walking intervention for seniors: a pilot study. Health Place. 2009 Mar; 15(1):173-9. PMID: 18502164.
        View in: PubMed
      81. Depp CA, Cain AE, Palmer BW, Moore D, Eyler LT, Lebowitz BD, Patterson TL, Jeste DV. Assessment of medication management ability in middle-aged and older adults with bipolar disorder. J Clin Psychopharmacol. 2008 Apr; 28(2):225-9. PMID: 18344736; PMCID: PMC3593666.
      82. Depp CA, Moore D, Patterson TL, Lebowitz BD, Jeste DV. Psychosocial interventions and medication adherence in bipolar disorder. Dialogues Clin Neurosci. 2008; 10(2):239-50. PMID: 18689293; PMCID: PMC3181867.
      83. Folsom DP, Gilmer T, Barrio C, Moore D, Bucardo J, Lindamer LA, Garcia P, Hawthorne W, Hough R, Patterson T, Jeste DV. A longitudinal study of the use of mental health services by persons with serious mental illness: do Spanish-speaking Latinos differ from English-speaking Latinos and Caucasians? Am J Psychiatry. 2007 Aug; 164(8):1173-80. PMID: 17671279.
        View in: PubMed
      84. Moore D, Sitzer D, Depp CA, Montross LP, Reichstadt J, Lebowitz BD, Jeste DV. Self-administered cognitive screening for a study of successful aging among community-dwelling seniors: a preliminary study. Int J Geriatr Psychiatry. 2007 Apr; 22(4):327-31. PMID: 17096466.
        View in: PubMed
      85. Depp CA, Moore D, Sitzer D, Palmer BW, Eyler LT, Roesch S, Lebowitz BD, Jeste DV. Neurocognitive impairment in middle-aged and older adults with bipolar disorder: comparison to schizophrenia and normal comparison subjects. J Affect Disord. 2007 Aug; 101(1-3):201-9. PMID: 17224185; PMCID: PMC1974900.
      86. Moore D, Savla GN, Woods SP, Jeste DV, Palmer BW. Verbal fluency impairments among middle-aged and older outpatients with schizophrenia are characterized by deficient switching. Schizophr Res. 2006 Oct; 87(1-3):254-60. PMID: 16854567.
        View in: PubMed
      87. Moore D, Masliah E, Rippeth JD, Gonzalez R, Carey CL, Cherner M, Ellis RJ, Achim CL, Marcotte TD, Heaton RK, Grant I. Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment. AIDS. 2006 Apr 04; 20(6):879-87. PMID: 16549972.
        View in: PubMed
      88. Nayak Savla G, Moore D, Roesch SC, Heaton RK, Jeste DV, Palmer BW. An evaluation of longitudinal neurocognitive performance among middle-aged and older schizophrenia patients: use of mixed-model analyses. Schizophr Res. 2006 Apr; 83(2-3):215-23. PMID: 16507344.
        View in: PubMed
      89. Montross LP, Depp C, Daly J, Reichstadt J, Golshan S, Moore D, Sitzer D, Jeste DV. Correlates of self-rated successful aging among community-dwelling older adults. Am J Geriatr Psychiatry. 2006 Jan; 14(1):43-51. PMID: 16407581.
        View in: PubMed
      90. Moore D, Palmer BW, Patterson TL, Jeste DV. A review of performance-based measures of functional living skills. J Psychiatr Res. 2007 Jan-Feb; 41(1-2):97-118. PMID: 16360706.
        View in: PubMed
      91. Braitstein P, Zala C, Yip B, Brinkhof MW, Moore D, Hogg RS, Montaner JS. Immunologic response to antiretroviral therapy in hepatitis C virus-coinfected adults in a population-based HIV/AIDS treatment program. J Infect Dis. 2006 Jan 15; 193(2):259-68. PMID: 16362890.
        View in: PubMed
      92. Jeste ND, Moore D, Goldman SR, Bucardo J, Davila-Fraga W, Golshan S, Jeste DV, Patterson TL. Predictors of everyday functioning among older Mexican Americans vs. Anglo-Americans with schizophrenia. J Clin Psychiatry. 2005 Oct; 66(10):1304-11. PMID: 16259545.
        View in: PubMed
      93. Patterson TL, Bucardo J, McKibbin CL, Mausbach BT, Moore D, Barrio C, Goldman SR, Jeste DV. Development and pilot testing of a new psychosocial intervention for older Latinos with chronic psychosis. Schizophr Bull. 2005 Oct; 31(4):922-30. PMID: 16037481.
        View in: PubMed
      94. Green DA, Masliah E, Vinters HV, Beizai P, Moore D, Achim CL. Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients. AIDS. 2005 Mar 04; 19(4):407-11. PMID: 15750394.
        View in: PubMed
      95. Moore D, Atkinson JH, Akiskal H, Gonzalez R, Wolfson T, Grant I. Temperament and risky behaviors: a pathway to HIV? J Affect Disord. 2005 Mar; 85(1-2):191-200. PMID: 15780689.
        View in: PubMed
      96. Gonzalez R, Rippeth JD, Carey CL, Heaton RK, Moore D, Schweinsburg BC, Cherner M, Grant I. Neurocognitive performance of methamphetamine users discordant for history of marijuana exposure. Drug Alcohol Depend. 2004 Nov 11; 76(2):181-90. PMID: 15488342.
        View in: PubMed
      97. Depp CA, Jin H, Mohamed S, Kaskow J, Moore D, Jeste DV. Bipolar disorder in middle-aged and elderly adults: is age of onset important? J Nerv Ment Dis. 2004 Nov; 192(11):796-9. PMID: 15505527.
        View in: PubMed
      98. Moore D, Palmer BW, Jeste DV. Use of the mini-mental state exam in middle-aged and older outpatients with schizophrenia: cognitive impairment and its associations. Am J Geriatr Psychiatry. 2004 Jul-Aug; 12(4):412-9. PMID: 15249279.
        View in: PubMed
      99. Heaton RK, Marcotte TD, Mindt MR, Sadek J, Moore D, Bentley H, McCutchan JA, Reicks C, Grant I. The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc. 2004 May; 10(3):317-31. PMID: 15147590.
        View in: PubMed
      100. Carey CL, Woods SP, Rippeth JD, Gonzalez R, Moore D, Marcotte TD, Grant I, Heaton RK. Initial validation of a screening battery for the detection of HIV-associated cognitive impairment. Clin Neuropsychol. 2004 May; 18(2):234-48. PMID: 15587671.
        View in: PubMed
      101. Rippeth JD, Heaton RK, Carey CL, Marcotte TD, Moore D, Gonzalez R, Wolfson T, Grant I. Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J Int Neuropsychol Soc. 2004 Jan; 10(1):1-14. PMID: 14751002.
        View in: PubMed
      102. Gladsjo JA, McAdams LA, Palmer BW, Moore D, Jeste DV, Heaton RK. A six-factor model of cognition in schizophrenia and related psychotic disorders: relationships with clinical symptoms and functional capacity. Schizophr Bull. 2004; 30(4):739-54. PMID: 15957196.
        View in: PubMed
      103. Marcotte TD, Deutsch R, McCutchan JA, Moore D, Letendre S, Ellis RJ, Wallace MR, Heaton RK, Grant I. Prediction of incident neurocognitive impairment by plasma HIV RNA and CD4 levels early after HIV seroconversion. Arch Neurol. 2003 Oct; 60(10):1406-12. PMID: 14568811.
        View in: PubMed
      104. Mindt MR, Cherner M, Marcotte TD, Moore D, Bentley H, Esquivel MM, Lopez Y, Grant I, Heaton RK. The functional impact of HIV-associated neuropsychological impairment in Spanish-speaking adults: a pilot study. J Clin Exp Neuropsychol. 2003 Feb; 25(1):122-32. PMID: 12607177; PMCID: PMC3737066.
      105. Gonzalez R, Heaton RK, Moore D, Letendre S, Ellis RJ, Wolfson T, Marcotte T, Cherner M, Rippeth J, Grant I. Computerized reaction time battery versus a traditional neuropsychological battery: detecting HIV-related impairments. J Int Neuropsychol Soc. 2003 Jan; 9(1):64-71. PMID: 12570359.
        View in: PubMed
      106. Cherner M, Masliah E, Ellis RJ, Marcotte TD, Moore D, Grant I, Heaton RK. Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis. Neurology. 2002 Nov 26; 59(10):1563-7. PMID: 12451198.
        View in: PubMed
      107. Ellis RJ, Moore D, Childers ME, Letendre S, McCutchan JA, Wolfson T, Spector SA, Hsia K, Heaton RK, Grant I. Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA. Arch Neurol. 2002 Jun; 59(6):923-8. PMID: 12056927.
        View in: PubMed
      David's Networks
      Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Similar People
      People who share similar concepts with this person.
      _
      Same Department
      Physical Neighbors
      People whose addresses are nearby this person.
      _